Patent · US Active

Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma

US8252793B2 · kind B2 · utility

0Cited by
17References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 17, 2011
Grant dateAug 28, 2012
Priority date
Expiry dateAug 17, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for treating and/or preventing ocular disorders associated with increased intraocular pressure. In particular, the compounds are bradykinin agonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.